Medicare Enrolled

Dr. Brian Kirby, M.D.

Rheumatology · Pensacola, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
8333 N DAVIS HWY, Pensacola, FL 32514
8504748387
In practice since 2006 (19 years)
NPI: 1588751473 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kirby from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kirby? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kirby

Dr. Brian Kirby is a rheumatology in Pensacola, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kirby performed 233,917 Medicare services across 1,955 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kirby received a total of $333,498 from 47 pharmaceutical and/or device companies across 1524 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kirby is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 5% volume in FL$ $333,498 industry payments

Medicare Practice Summary

Medicare Utilization ↗
233,917
Medicare services
Top 5% in FL for rheumatology
1,955
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~12,311 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Tocilizumab injection (Actemra)136,568$5$9
Golimumab infusion (Simponi Aria)33,226$10$41
Romosozumab injection (Evenity) for osteoporosis24,990$8$14
Denosumab injection (Prolia/Xgeva)16,080$18$36
Abatacept infusion (Orencia)14,525$34$110
Infliximab infusion (Remicade)4,430$26$115
Office visit, established patient (30-39 min)1,245$88$195
Steroid injection (triamcinolone)504$1$4
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less412$49$143
Drug injection, under skin or into muscle404$11$28
Administration of chemotherapy into vein, 1 hour or less369$97$278
Complete ultrasound scan of joint231$8$131
Administration of chemotherapy into vein, each additional hour188$22$61
New patient office visit (45-59 min)174$123$247
Injection, zoledronic acid, 1 mg135$6$150
Bone density scan (DEXA)104$37$74
Joint injection, major joint96$50$123
Office visit, established patient (20-29 min)89$62$137
Injection of additional new drug or substance into vein61$12$35
Injection, diphenhydramine hcl, up to 50 mg33$1$2
Injection, methylprednisolone sodium succinate, up to 125 mg32$4$12
Aspiration and/or injection of fluid from small joint21$39$104
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.5% high complexity
76.8% medium
0.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$333,498
Total received (2018-2024)
Avg $47,643/year across 7 years
Top 5% in FL for rheumatology
47
Companies
1,524
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$285,377 (85.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$28,398 (8.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,723 (5.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$38,330
2023
$78,922
2022
$57,225
2021
$39,872
2020
$13,363
2019
$62,031
2018
$43,754

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$68,398
Novartis Pharmaceuticals Corporation
$68,176
GlaxoSmithKline, LLC.
$66,250
Aurinia Pharma U.S., Inc.
$49,540
PFIZER INC.
$29,297
Regeneron Healthcare Solutions, Inc.
$19,316
GENZYME CORPORATION
$16,812
ABBVIE INC.
$2,422
Nuvectra Corporation
$1,816
Janssen Biotech, Inc.
$1,779
UCB, Inc.
$1,546
AbbVie Inc.
$1,213
Radius Health, Inc.
$1,005
AbbVie, Inc.
$856
Horizon Therapeutics plc
$720
E.R. Squibb & Sons, L.L.C.
$711
Boehringer Ingelheim Pharmaceuticals, Inc.
$616
Mallinckrodt Hospital Products Inc.
$516
Lilly USA, LLC
$466
AstraZeneca Pharmaceuticals LP
$339
Alexion Pharmaceuticals, Inc.
$282
Genentech USA, Inc.
$216
SANOFI-AVENTIS U.S. LLC
$120
Kiniksa Pharmaceuticals International, plc
$94
Janssen Scientific Affairs, LLC
$94
Sobi, Inc
$88
Fresenius Kabi USA, LLC
$84
Octapharma USA, Inc.
$80
Celgene Corporation
$70
Sandoz Inc.
$65
Abbott Laboratories
$59
Johnson & Johnson Health Care Systems Inc.
$57
Horizon Pharma plc
$51
Mallinckrodt Enterprises LLC
$46
SOBI, INC
$43
Takeda Pharmaceuticals U.S.A., Inc.
$39
Merck Sharp & Dohme Corporation
$32
SCILEX PHARMACEUTICALS INC.
$30
United Therapeutics Corporation
$25
IMPEL PHARMACEUTICALS INC.
$22
Ultragenyx Pharmaceutical Inc.
$19
Smith+Nephew, Inc.
$18
Bioventus LLC
$16
Kyowa Kirin, Inc.
$15
Organon Llc
$15
IBSA Pharma Inc.
$14
Purdue Pharma L.P.
$11
Top 3 companies account for 60.8% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Algovita · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUROLANE · EMBEDA · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LICART · LUPKYNIS · LYRICA · NO PRODUCT DISCUSSED · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PICO 7 Single Use Negative Pressure Wound Therapy · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SCS IPGs · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYMPROIC · Strensiq · TALTZ · TAVNEOS · TREMFYA · TYVASO · Tavneos · Trudhesa · Tymlos · Uloric · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for rheumatology in FL.

Equivalent to $143 per 100 Medicare services performed
Looking for a rheumatology in Pensacola?
Compare rheumatologys in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
14
Per 100K population
4.3
County median income
$65,715
Nearest hospital
HCA FLORIDA WEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kirby is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and high industry engagement (speaking/promotional, top 5%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kirby experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Kirby performed 136,568 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kirby receive payments from pharmaceutical companies?
Yes. Dr. Kirby received a total of $333,498 from 47 companies across 1,524 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kirby's costs compare to other rheumatologys in Pensacola?
Dr. Kirby's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kirby) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →